Tag: ($14.00)

Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year

Atara Biotherapeutics Reports Strong Q4 Revenue Growth and Strategic Updates Atara Biotherapeutics, a leading biopharmaceutical company focused on innovative therapies for serious diseases, recently announced...

Popular Articles